Hematopoietic and lymphocytic neoplasms (HLNs) are a diverse group of malignancies affecting blood and lymphatic systems, with outcomes varying from manageable conditions to fatal diseases.

Eosinophilic esophagitis (EoE) is an emerging chronic food allergy disease that affects the esophagus. We use cookies to deliver the best possible experience on our website. To learn more, visit our ...

FARE to Debut Two New Videos at AAAAI/WAO Joint Congress, Including PSA on Early Allergen Introduction and Documentary on ...

In the next in our series on rare conditions that GPs might only encounter once in a career, Dr James Chambers discusses this ...

Following results that have sent the stock northward, Research Capital analyst Andre Uddin remains bullish on Eupraxia ...

Shares of Innergex Renewable Energy jumped 54%, to 13.40 Canadian dollars (US$9.40), after the Caisse de Depot et Placement du Quebec moved to buy the power producer in a deal that represents an ...

A 30-year-old New England woman’s symptoms started with a burning sensation in her feet. Over the following two days, the ...

Eupraxia Pharmaceuticals shares rose in premarket trading Tuesday after the company said it received positive data from its eosinophilic esophagitis treatment trials. Shares traded nearly 6.3% higher ...

Eupraxia Pharmaceuticals Inc. shares T.EPRX are trading unchanged at $5.33.

Craig-Hallum analyst Albert Lowe maintained a Buy rating on Eupraxia Pharmaceuticals (EPRX – Research Report) today. The company’s shares ...

Eupraxia Pharmaceuticals (EPRX) announced additional positive clinical data from its ongoing RESOLVE Phase 1b/2a trial evaluating EP-104GI for ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...